These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000813-36 A phase II, multicentre, single-arm, open-label study of subcutaneous homoharringtonine (HHT) alone in patients with accelerated phase chronic myeloid leukemia (CML) who are refractory to, or have rel... 2007-10-01 due-trials
Not reported 2005-000814-11 A phase II, multicentre, open-label, single arm, extension study of maintenance treatment with subcutaneous homoharringtonine (HHT) as a single agent in patients with chronic myeloid leukemia (CML) wh... 2007-10-01 due-trials
Reported results 2006-000176-32 A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) with the T315I BCR-ABL Gene Mutation 2013-08-05 due-trials
Ongoing 2006-004517-17 A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Refractory or Relapsed Acute Myeloid Leukemia (AML) not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-001286-15 A Phase II Open-Label Study of the Subcutaneous Administration of Homoharringtonine (CGX-635) in the Treatment of Patients with Chronic Myeloid Leukemia (CML) who have failed or are intolerant to tyro... 2013-06-27 bad-data